Anti-L-selectin monoclonal antibodies (PDL BioPharma) | Interleukin Related interleukin-related.com

Product Name :
Anti-L-selectin monoclonal antibodies (PDL BioPharma)

Search keywords :
Aselizumab

drugId :
null

Target Vo:
Leukocyte adhesion molecule-1

Target Vo Short Name :
LYAM1

Moa_Name:
Leukocyte adhesion molecule-1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pdl Biopharma Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Crohn Disease

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glucose 6 Phosphate Dehydrogenase Antibody
Glutamine Synthetase Antibody (YA751)
BrdU Antibody (YA818): BrdU Antibody (YA818) is a non-conjugated and Mouse origined monoclonal antibody, targeting to BrdU. It can be used for ICC/IF assays with tag free, in the background of Species independent.

Author: Interleukin Related

Related Posts